InSite One Inc.

InSite One hopes to provide hospitals with an archiving solution that accommodates radiologists' needs for on-line and off-line storage of images and short and long-term access to those images. The company will operate under a fee-for-service model that will relieve hospitals of the expense and obsolescence risk of buying capital equipment.

Image archiving is a throwback in the evolution of digital radiology. Today, many medical centers have the ability to digitally capture medical images acquired from computed radiography (CR), CT scans, MRI, or nuclear medicine. Radiologists can, within minutes, manipulate such images on a workstation, run them through pattern recognition software that helps in interpretation, and send them over the Internet to clinicians in remote locations. But six months later, if a clinician wants to call back images, at most hospitals —even those select few hospitals that are digitally equipped from one end to the other— the process works something like this: A departmental clerk goes to the hospital file room with a shopping cart and fills it with envelopes containing archived, film-based studies. Turn-around time on old film requests—four hours to two days, with 5-8% lost or missing rate. So much for progress.

Hospitals lack sufficient capacity to archive images electronically. Ironically, images that are acquired digitally are often converted to film for...

More from Strategy

More from Business

Somnee AI-Powered Sleep Wearable Raises $10M Seed Round

 

The $10m seed extension funding round will be used to launch the second-generation wearable headband with the added SmartSleep AI operating system.

Intuitive Surgical Projects $165M Tariff Hit In 2025, Says Wait-And-See On Mitigation

 
• By 

Despite near-term cost pressures, Intuitive Surgical is expanding manufacturing and R&D in North America and Europe to meet demand for Ion, X and Xi systems.

Three Steps To Investor Heaven For Medtech Founders: Articulate, Explain, Clarify

 
• By 

Capital remains available for good healthtech projects, but it is more concentrated and harder to find than of late. Founders and inventors must know how to unlock it. The BioWales 2025 investor panel told them where they could be going wrong.